Publicaciones
-
Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.
FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia
PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Nº de citas: 5
-
Sánchez-Martínez D, Baroni ML, Gutierrez-Agüera F, Roca-Ho H, Blanch-Lombarte O, González-García S, Torrebadell-Burriel M, Junca J, Ramírez-Orellana M, Velasco-Hernández T, Bueno C, Fuster JL, Prado JG, Calvo J, Uzan B, Cools J, Camós-Guijosa M, Pflumio F, Toribio ML and Menéndez P.
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.
Blood . 133(21): 2291-2304. Nº de citas: 83
-
Torrebadell-Burriel M, Diaz-Beya M, Kalko SG, Pratcorona M, Nomdedeu J, Navarro A, Gel B, Brunet S, Sierra J, Camós-Guijosa M and Esteve J.
A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.
LEUKEMIA & LYMPHOMA . 59(10): 2394-2404. Nº de citas: 14
-
Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue-Meda M, Pont-Martí S, Rives-Solà S and Camós-Guijosa M.
Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases
BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553. Nº de citas: 7
-
Robles-Valero J, Lorenzo-Martín LF, Menacho-Márquez M, Fernández-Pisonero I, Abad A, Camós-Guijosa M, Toribio ML, Espinosa L, Bigas A and Bustelo XR.
A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia.
Cancer Cell . 32(5): 608-6239. Nº de citas: 29
-
Forero-Castro M, Robledo C, Benito R, Bodega-Mayor I, Rapado I, Hernández-Sánchez M, Abáigar M, Maria Hernández-Sánchez J, Quijada-Álamo M, María Sánchez-Pina J, Sala-Valdés M, Araujo-Silva F, Kohlmann A, Luis Fuster J, Arefi M, de Las Heras N, Riesco S, Rodríguez JN, Hermosín L, Ribera J, Camós-Guijosa M, Ramírez M, de Heredia Rubio CD, Barragán E, Martínez J, Ribera JM, Fernández-Ruiz E and Hernández-Rivas JM.
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
BRITISH JOURNAL OF CANCER . 117(2): 256-265. Nº de citas: 32
-
Català-Temprano A, Pastor-Anglada M, Caviedes-Cárdenas L, Malatesta R, Rives-Solà S, Vega-García N, Camós-Guijosa M and Fernández-Calotti P.
FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia
Oncotarget . 7(31): 49786-49799. Nº de citas: 12
-
Gianesin K, Noguera-Julián A, Zanchetta M, Del Bianco P, Petrara MR, Freguja R, Rampon O, Fortuny-Guasch C, Camós-Guijosa M, Mozzo E, Giaquinto C and De Rossi A.
Premature aging and immune senescence in HIV-infected children
Aids . 30(9): 1363-1373. Nº de citas: 75
-
Prieto C, Stam RW, Agraz-Doblas A, Ballerini P, Camós-Guijosa M, Castaño J, Marschalek R, Bursen A, Varela I, Bueno C and Menendez P.
Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34(+) HSPC But Is Insufficient to Initiate Leukemia
CANCER RESEARCH . 76(8): 2478-2489. Nº de citas: 33
-
Berrueco R, Alonso-Saladrigues A, Martorell-Sampol L, Català-Temprano A, Ruiz-Llobet A, Toll T, Torrebadell-Burriel M, Naudo-Lahoz M, Camós-Guijosa M and Rives-Solà S.
Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening
PEDIATRIC BLOOD & CANCER . 62(7): 1195-1201. Nº de citas: 8